The enigmatic nature of the triggering receptor expressed in myeloid cells -1 (TLT- 1)

Platelets. 2021 Aug 18;32(6):753-760. doi: 10.1080/09537104.2021.1881948. Epub 2021 Feb 9.

Abstract

Receptors are important pharmacological targets on cells. The Triggering Receptor Expressed on Myeloid Cells (TREM) - Like Transcript - 1 is an abundant, yet little understood, platelet receptor. It is a single Ig domain containing receptor isolated in the α-granules of resting platelets and brought to the platelet surface upon activation. On platelets, the integrin αIIbβ3 is the major receptor having roughly 80,000 copies. αIIbβ3 is a heterodimeric multidomain structure that mediates platelet aggregation through its interaction with the plasma protein fibrinogen. Anti-platelet drugs have successfully targeted αIIbβ3 to control thrombosis. Like αIIbβ3, TLT-1 also binds fibrinogen, making its role in platelet function somewhat obscure. In this review, we highlight the known structural features of TLT-1 and present the challenges of understanding TLT-1 function. In our analysis of the dynamics of the platelet surface after activation we propose a model in which TLT-1 supports αIIbβ3 function as a mechanoreceptor that may direct platelets toward immune function.

Keywords: Blood platelets; fibrinogen; lungs; neutrophils; platelet receptors; trem-Like transcript-1 (TLT-1); αIIbβ3.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Platelets / metabolism*
  • Disease Models, Animal
  • Humans
  • Mice
  • Models, Molecular
  • Myeloid Cells / metabolism*